Updates are available Correction dated 2023-10-27
Click to view Correction: https://doi.org/10.1007/s10620-023-08130-w
-
Authors
Berinstein, Elliot M.
Sheehan, Jessica L
Jacob, Janson
Steiner, Calen A.
Stidham, Ryan W.
Shannon, Carol
Bishu, Shrinivas
Levine, Jake
Cohen-Mekelburg, Shirley A.
Waljee, Akbar K.
Higgins, Peter D. R.
Berinstein, Jeffrey A. https://orcid.org/0000-0001-7631-9665
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 13 January 2023
First Online: 20 February 2023
Change Date: 27 October 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10620-023-08130-w
Declarations
:
: PDRH received consulting fees from AbbVie, Amgen, Genentech, and Pfizer. RWS received consulting fees from AbbVie, Janssen, Takeda, Merck, Gilead, Eli Lily, Exact Science, Evergreen Pharmaceuticals, Corrona LLC. JAB received consulting fees from BUHLMANN Diagnostics Corp. All other authors report no relevant disclosures.
